Trajectories of peripheral interleukin-6, structure of the hippocampus, and cognitive impairment over 14 years in older adults

Neurobiology of Aging

Volumn 36, Issue 11, 2015, Pages 3038-3044

  Metti, Andrea L ^a   Aizenstein, Howard ^b   Yaffe, Kristine ^c,d   Boudreau, Robert M ^e   Newman, Anne ^e   Launer, Lenore ^f   Gianaros, Peter J ^b   Lopez, Oscar L ^b   Saxton, Judith ^b   Ives, Diane G ^e   Kritchevsky, Stephen ^g   Vallejo, Abbe N ^h   Rosano, Caterina ^e  

^a Metti Consulting Company   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f NATIONAL INSTITUTE ON AGING   (United States)

^g WAKE FOREST SCHOOL OF MEDICINE   (United States)

^h CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Aging; Cognitive impairment; Epidemiology; Hippocampal morphology; Interleukin 6

Indexed keywords

INTERLEUKIN 6; IL6 PROTEIN, HUMAN;

AGED; ARTICLE; BRAIN SIZE; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMAN; INTERVENTION STUDY; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; AGING; METABOLISM; NEUROIMAGING; PATHOLOGY; PROSPECTIVE STUDY; REGRESSION ANALYSIS; TIME FACTOR;

AGED; AGING; COGNITION DISORDERS; COHORT STUDIES; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMANS; INTERLEUKIN-6; MALE; NEUROIMAGING; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; TIME FACTORS;

EID: 84947020515     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.07.025     Document Type: Article

References (48)

1. Banks W.A., Kastin A.J. Blood to brain transport of interleukin links the immune and central nervous systems. Life Sci. 1991, 48:PL117-PL121.
2. Baune B.T., Konrad C., Grotegerd D., Suslow T., Birosova E., Ohrmann P., Bauer J., Arolt V., Heindel W., Domschke K., Schoning S., Rauch A.V., Uhlmann C., Kugel H., Dannlowski U. Interleukin-6 gene (IL-6): a possible role in brain morphology in the healthy adult brain. J. Neuroinflammation 2012, 9:125.
3. Cappola A.R., O'Meara E.S., Guo W., Bartz T.M., Fried L.F., Newman A.B. Trajectories of dehydroepiandrosterone sulfate predict mortality in older adults: the Cardiovascular Health Study. J. Gerontol. A Biol. Sci. Med. Sci. 2009, 64:1268-1274.
4. Chen S.-Y., Chen T.-F., Lai L.-C., Chen J.-H., Sun Y., Wen L.-L., Yip P.-K., Chu Y.-M., Chen Y.-C. Sequence variants of interleukin-6 (IL-6) are significantly associated with a decreased risk of late-onset Alzheimer's disease. J. Neuroinflammation 2012, 9:21.
5. deGoma E.M., French B., Dunbar R., Allison M.A., Mohler E.R.I., Budoff M.J. Intraindividual variability of c-reactive protein: the multi-ethnic study of atherosclerosis. Atherosclerosis 2012, 224:274-279.
6. Economos A., Wright C.B., Moon Y.P., Rundek T., Rabbani L., Paik M.C., Sacco R.L., Elkind M.S.V. Interleukin 6 plasma concentration associates with cognitive decline: the northern Manhattan study. Neuroepidemiology 2013, 40:253-259.
7. Elderkin-Thompson V., Irwin M.R., Hellemann G., Kumar A. Interleukin-6 and memory functions of encoding and recall in healthy and depressed elderly adults. Am. J. Geriatr. Psychiatry 2012, 20:753-763.
8. Frodl T., Amico F. Is there an association between peripheral immune markers and structural/functional neuroimaging findings?. Prog. Neuropsychopharmacol. Biol. Psychol. 2014, 48:295-303.
9. Gadient R.A., Otten U. Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development. Brain Res. 1994, 637:10-14.
10. Gianaros P.J., Marsland A.L., Kuan D.C., Schirda B.L., Jennings R., Sheu L.K., Hariri A.R., Gross J.J., Manuck S.B. An inflammatory pathway links atherosclerotic cardiovascular disease risk to neural activity evoked by the cognitive regulation of emotion. Biol. Psychiatry 2014, 75:738-745.
11. Grassi-Oliveira R., Bauer M.E., Pezzi J.C., Teixeira A.L., Brietzke E. Interleukin-6 and verbal memory in recurrent major depressive disorder. Neuro Endocrinol. Lett. 2011, 32:540-544.
12. Hampel H., Haslinger A., Scheloske M., Padberg F., Fishcher P., Unger J., Teipel S.J., Neumann M., Rosenberg C., Oshida R., Hulette C., Pongratz D., Ewers M., Kretzschmar H.A., Moller H.J. Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brain. Eur. Arch. Psychiatry Clin. Neurosci. 2005, 255:269-278.
13. Harrison N.A., Cercignani M., Voon V., Critchley H.D. Effects of inflammation on hippocampus and substantia nigra responses to novelty in healthy human participants. Neuropsychopharmachology 2014, 40:831-838.
14. Harrison N.A., Doeller C.F., Voon V., Burgess N., Critchley H.D. Peripheral inflammation acutely impairs human spatial memory via actions on medial temporal lobe glucose metabolism. Biol. Psychiatry 2014, 76:585-593.
15. Hixson J., Vernier D. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J. Lipid Res. 1990, 31:545-548.
16. Hunter C.A., Jones S.A. IL-6 as a keystone cytokine in health and disease. Nat. Immunol. 2015, 16:448-457.
17. Jenny N.S., French B., Arnold A.M., Strotmeyer E.S., Cushman M., Chaves P.H., Ding J., Fried L.P., Kritchevsky S.B., Rifkin D.E., Sarnak M.J., Newman A.B. Long-term assessment of inflammation and healthy aging in late life: the Cardiovascular Health Study All Stars. J. Gerontol. A Biol. Sci. Med. Sci. 2012, 67:970-976.
18. Kalmady S.V., Venkatasubramanian G., Shivakumar V., Gautham S., Subramaniam A., Jose D.A., Maitra A., Ravi V., Gangadhar B.N. Relationship between Interleukin-6 gene polymorphism and hippocampal volume in antipsychotic-naive schizophrenia: evidence for differential susceptibility. PLoS One 2014, 9:e96021.
19. Kaup A.R., Simonsick E.M., Harris T.B., Satterfield S., Metti A.L., Ayonayon H.N., Rubin S., Yaffe K. Older adults with limited literacy are at increased risk for likely dementia. J. Gerontol. A Biol. Sci. Med. Sci. 2013, 69:900-906.
20. Kesler S., Janelsins M., Koovakkattu D., Palesh O., Mustian K., Morrow G., Dhabha F.S. Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain Behav. Immun. 2013, 30:S109-S116.
21. Kivipelto M., Helkala E.-L., Laakso M.P., Hanninen T., Hallikainen M., Alhainen K., Soininen H., Tuomilehto J., Nissien A. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001, 322:1447-1451.
22. Koenig W., Sund M., Frolich M., Lowel H., Hutchinson W.L., Pepys M.B. Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time. The MONICA Augsburgh Studies, 1984 and 1987. Am. J. Epidemiol. 2003, 158:357-364.
23. Kravitz B.A., Corrada M.M., Kawas C.H. Elevated c-reactive protein levels are associated with prevalent dementia in the oldest old. Alzheimers Dement. 2009, 5:318-323.
24. Lopez O.L., Jagust W.J., DeKosky S.T., Becker J.T., Fitzpatrick A., Dulberg C., Breitner J., Lyketsos C., Jones B., Kawas C., Carlson M., Kuller L.H. Prevalence and classification of mild cognitive impairment in the cardiovascular health study cognition study. Part 1. Arch. Neurol. 2003, 60:1385-1389.
25. Maier S.F., Watkins L.R. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood and cognition. Psychol. Rev. 1998, 105:83-107.
26. Marsland A.L. Inflammation. Neuropsychology of Cardiovascular Disease 2011, Psychology Press, East Sussex, United kingdom. second ed. S.R. Waldstein, M.F. Elias (Eds.).
27. Marsland A.L., Gianaros P.J., Abramowitch S.M., Manuck S.B., Hariri A.R. Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol. Psychiatry 2008, 64:484-490.
28. Metti A.L., Yaffe K., Ayonayon H.N., Carnahan R., Robbins G., Simonsick E.M., Cauley J.A. Trajectories of inflammatory markers and cognitive decline over 10 years. Neurobiol. Aging 2014, 35:2785-2790.
29. Mooijaart S.P., Sattar N., Trompet S., Lucke J., Stott D.J., Ford I., Jukema J.W., Westendorp R.G.J., De Craen A.J.M. Circulating interleukin-6 concentration and cognitive decline in old age: the PROSPER study. J. Intern. Med. 2013, 274:77-85. PROSPER Study Group.
30. Pahor M., Chrischilles E.A., Guralink J.M., Brown S.L., Wallace R.B., Carbonin P. Drug data coding and analysis in epidemiologic studies. Eur. J. Epidemiol. 1994, 10:405-411.
31. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1977, 1:385-401.
32. Rosano C., Aizenstein H.J., Newman A.B., Venkatraman V., Harris T., Ding J., Satterfield S., Yaffe K. Neuroimaging differences between older adults with maintained versus declining cognition over a 10-year period. Neuroimage 2012, 62:307-313. for the Health ABC study.
33. Savitz J., Frank M.B., Victor T., Bebak M., Marino J.H., Bellgowan P.S., McKinney B.A., Bodurka J., Kent Teague T., Drevets W.C. Inflammation and neurological disease-related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional imaging abnormalities. Brain Behav. Immun. 2013, 31:161-171.
34. Schmidt R., Schmidt H., Curb J.D., Masaki K., White L.R., Launer L.J. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann. Neurol. 2002, 52:168-174.
35. Schobitz B., De Kloet E.R., Holsboer F. Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain. Prog. Neurobiol. 1994, 44:397-432.
36. Schram M.T., Euser S.M., De Craen A.J.M., Witteman J.C., Frolich M., Hofman A., Jolles J., Breteler M.M.B., Westendorp R.G.J. Systemic markers of inflammation and cognitive decline in old age. J. Am. Geriatr. Soc. 2007, 55:708-716.
37. Shah N.S., Vidal J.S., Masaki K., Petrovitch H., Ross G.W., Tilley C., DeMattos R.B., Tracy R.P., White L.R., Launer L.J. Midlife blood pressure, plasma beta-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study. Hypertension 2012, 59:780-786.
38. Singh T., Newman A.B. Inflammatory markers in population studies of aging. Ageing Res. Rev. 2011, 10:319-329.
39. Slinin Y., Paudel M.L., Taylor B.C., Fink H.A., Ishani A., Canales M.T., Yaffe K., Barrett-Connor E., Orwoll E.S., Shikany J.M., Leblanc E.S., Cauley J.A., Ensrud K.E. 25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology 2010, 74:33-41. Group, O. F. i. M. M. S. R.
40. Smith S.M., Jenkinson M., Woolrich M.W., Beckmann C.F., Behrens T.E., Johansen-Berg H., Bannister P.R., De Luca M., Drobnjak I., Flitney D.E., Niazy R.K., Saunders J., VIckers J., Zhang Y., De Stefano N., Brady J.M., Matthews P.M. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004, 23:S208-S219.
41. Tracey K.J. The inflammatory reflex. Nature 2002, 420:853-859.
42. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Corivello F., Etard O., Delcroix N., Mazoyer B., Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002, 15:273-289.
43. Vallejo A.N., Hamel D.L.J., Mueller R.G., Ives D.G., Michel J.J., Boudreau R.M., Newman A.B. NK-like T cells and plasma cytokines, but not anti-viral serology, define immune fingerprints of resilience and mild disability in exceptional aging. PLoS One 2011, 6:e26558.
44. Vitovic L., Konsman J.P., Bockaert J., Dantzer R., Homburger V., Jacque C. Cytokine signals propagate through the brain. Mol. Psychiatry 2000, 5:604-615.
45. Yaffe K., Blackwell T., Kanaya A.M., Davidowitz N., Barrett-Connor E., Krueger K. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 2004, 63:658-663.
46. Yaffe K., Falvey C., Harris T.B., Newman A., Satterfield S., Koster A., Ayonayon H., Simonsick E. Effect of socioeconomic disparities on incidence of dementia among biracial older adults: prospective study. BMJ 2013, 347:1-9. for the Health ABC Study.
47. Yaffe K., Lindquist K., Penninx B.W., Simonsick E.M., Pahor M., Kritchevsky S., Launer L., Kuller L., Rubin S., Harris T. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 2003, 61:76-80.
48. Yaffe K., Weston A.L., Blackwell T., Krueger K. The metabolic syndrome and development of cognitive impairment among older women. Arch. Neurol. 2009, 66:324-328.